Viewing StudyNCT00511576

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00511576
Status: TERMINATED
Last Update Posted: 2015-01-08
First Post: 2007-08-03
Brief Title: Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel Taxotere for Subjects With Advanced Cancer Tumors
Sponsor: Mirati Therapeutics Inc
Organization: Mirati Therapeutics Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Stomach Cancer
Breast Cancer
Lung Cancer
Pulmonary Cancer
Non-Small-Cell Lung Carcinoma
Prostate Cancer
Prostatic Cancer
Gastric Cancer
Keywords:
Name View
Docetaxel View
Advanced or Metastatic Breast Cancer View
Breast Cancer View
Advanced or Metastatic Non-Small-Cell Lung Cancer NSCLC View
Hormone Refractory Prostate Cancer View
Prostate Cancer View
Gastric Cancer View
Advanced Gastric Adenocarcinoma View
HDAC Inhibitor View
Taxotere View